ArticleFrontiers in neurology2025
Efficacy of 3D slicer-assisted minimally invasive thrombolysis combined with soft channel drainage versus craniotomy: a retrospective study in moderate basal ganglia hemorrhage.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The optimal clinical treatment strategy for moderate basal ganglia hemorrhage (30-50 mL) remains a subject of debate. This study aims to evaluate the clinical efficacy of 3D Slicer-assisted minimally invasive thrombolysis combined with soft channel drainage by comparing it with traditional craniotomy, thus assessing the clinical value of this minimally invasive approach. Methods: In this retrospective study, the patients were divided into the minimally invasive group and the craniotomy group based on surgical approaches. The study compared operative time, hematoma clearance rates, and postoperative complication rates between the two groups. Functional recovery was assessed at 6 months postoperatively using the modified Rankin Scale (mRS) and Barthel Index. Additionally, the study analyzed differences in medical costs and cost-effectiveness between the two treatment approaches. Results: A total of 112 patients were enrolled, with 41 in the minimally invasive group and 71 in the craniotomy group. Baseline characteristics showed no significant differences between groups (all Conclusion: 3D Slicer-assisted minimally invasive thrombolysis combined with soft channel drainage represents an effective treatment for patients with moderate basal ganglia hemorrhage. It offers several advantages, including precise localization, minimal surgical trauma, a low complication rate, favorable safety profile, and cost-effectiveness. Therefore, this minimally invasive technique holds significant clinical value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.